[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100591185":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":31,"collaborators":7,"id":35,"slug":7,"hasResults":36,"nctId":37,"briefTitle":38,"officialTitle":38,"acronym":39,"eligibilityCriteria":40,"healthyVolunteers":36,"sex":41,"minAge":42,"maxAge":7,"enrollmentInfo":43,"targetDuration":7,"studyType":46,"phases":7,"briefSummary":47,"conditions":48,"keywords":7,"overallStatus":17,"whyStopped":7,"lastUpdateSubmitDate":50,"lastUpdatePostDateStruct":51,"startDateStruct":54,"completionDateStruct":56,"leadSponsor":58,"locationsCount":59},{"fullName":5,"class":6},"University of Luebeck","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Ingo Eitel, Prof. Dr.","CONTACT","+49 451 500 44501","cvro@uksh.de",[15],{"facility":16,"status":17,"city":18,"state":19,"zip":7,"country":20,"countryCode":21,"cosmosGeoPoint":22,"geoPoint":27,"contacts":28},"Universitätsklinikum Schleswig-Holstein","RECRUITING","Lübeck","Schleswig-Holstein","Germany","DE",{"type":23,"coordinates":24},"Point",[25,26],10.68729,53.86893,{"lat":26,"lon":25},[29],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":30},"ingo.eitel@uksh.de",{"type":32,"investigatorFullName":33,"investigatorTitle":34,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"SPONSOR_INVESTIGATOR","Prof. Dr. med. Ingo Eitel","Head of Department","100591185",false,"NCT06977139","Interventional Structural Registry - LuEbeck","INSTYLE","Inclusion Criteria:\n\n* Structural heart disease\n\nExclusion Criteria:\n\n* Patients without consent\u002Finformation\n* Age ≤ 18 years","ALL","18 Years",{"count":44,"type":45},2000,"ESTIMATED","OBSERVATIONAL","The aim of the registry is to investigate the effect of catheter-assisted procedures in the context of structural heart disease on clinical morbidity and mortality. Furthermore, the long-term prognosis of patients after a catheter-based procedure is to be evaluated.\n\nIn particular, the following parameters will be documented and the following questions discussed:\n\n* Underlying and concomitant diseases of these patients\n* Evaluation of the methods in relation to the respective disease\n* Safety - acute and long-term\n* Effectiveness - periprocedural, hospital and long-term course\n* Concomitant therapies",[49],"Structural Heart Disease","2025-05-08",{"date":52,"type":53},"2025-05-18","ACTUAL",{"date":55,"type":53},"2021-09-11",{"date":57,"type":45},"2035-01-01",{"name":33,"class":6},1]